Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prucalopride for intestinal recovery after radical cystectomy
NCT05001763Phase 2Unknown
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Sep 2021
- Primary completion
- Sep 2023
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in postoperative ileus (POI) comparing Placebo with Prucalopride (2 arms). Primary endpoint: Time to defecation at 30 days. Status: unknown.
02
Drugs
prucalopride
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on NCT05001763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05001763.